Stem Cells in Drug Discovery
February 26, 2009—Berlin, Germany (9:00am—12:30pm)
Presented by Enal Razvi, Ph.D.
Select Biosciences welcomes you to attend a half day interactive market analysis/business tutorial presented by Enal Razvi, Ph.D. This market analysis tutorial will be held following the Screening Europe 2009 Conference. Attendees will have the opportunity of acquiring the new Stem Cells in Drug Discovery 2009 Market Report in the delegate package. This will include results and conclusions from our various market surveys on the stem cells space and an up-to-date and thorough market analysis/opportunity assessment of stem cell utilization in drug discovery; the package represents a considerable saving over the normal list price.
Introduction to the Tutorial
Select Biosciences has been continually tracking the stem cells marketplace since 2006 and as the field has matured and evolved, our industry tracking is focusing on the emerging segments of this market and the opportunities therein. Select Biosciences is now focusing its stem cells industry coverage on the following segments:
v Stem cells in regenerative medicine
v Stem cells in drug discovery
This market analysis tutorial focuses upon the landscape of stem cells in drug discovery—specific topics covered are the types of stem cells utilized currently and forecast for the future, application areas, quantitative market metrics, market surveys on this topic, market forecast, challenges, emerging market segments, and companies in the space.
All attendees will receive electronic copies of the various market analyses presented, to complement the presentation and discussion. This is a fast-paced business-focused tutorial, which will include a round-table discussion with your fellow attendees and an un-paralleled networking opportunity with industry participants from around the world working in similar spaces.
Specific Topics Covered in this Tutorial
v Overview of the market landscape: Utilization of stem cells in drug discovery and toxicity screening
v Quantitative Market Analysis: Types of stem cells utilized, growth of individual segments, sizing of the market in each application area
v Market Surveys that Reveal the Current Landscape and Emerging Trends: Data and analyses are presented to reveal trends
v Review of the Various Technologies and Types of Stem Cells Utilized in Drug Discovery and Key Product Offerings in the Space
v Emerging Opportunities to the Product/Service Vendors: Qualitative and quantitative picture
v Companies, Institutions in the Space: Worldwide
v Interactive Round-table Discussion and Networking
Who Should Attend
v Scientists in Pharmaceutical and Biotechnology companies
v Business Development, Licensing, and Marketing Executives in Pharmaceutical and Biotechnology companies
v Representatives from Academic Institutions (Licensing and Technology Transfer)
v Established and start-up companies in stem cells space and vendors seeking to offer products into the space
v Venture Capital community and investors seeking to understand the stem cell market landscape, and associated business opportunities
Learning Objectives/Themes
v Overview of the market landscape for stem cells in drug discovery
v Market analysis: Qualitative and quantitative
v Emerging business opportunities, and associated challenges
v Review of the various technologies and products in the space
v Landscape of companies/institutions (worldwide) in the space
v Interactive round table discussion and networking with attendees from around the world
Toxicity Screening and Key Target Classes
February 26, 2009—Berlin, Germany (13:30—17:00)
Presented by Enal Razvi, Ph.D.
Select Biosciences welcomes you to attend a half day interactive market analysis/business tutorial presented by Enal Razvi, Ph.D. This market analysis tutorial will be held following the Screening Europe 2009 Conference. Attendees will have the opportunity of acquiring the new Toxicity Screening 2009 Market Report in the delegate package. This will include results and conclusions from our various market surveys on the toxicity space and an up-to-date and market analysis/opportunity assessment of toxicity screening in drug discovery; the package represents a considerable saving over the normal list price.
Introduction to the Tutorial
Select Biosciences has been tracking various segments of the drug discovery marketplace over the past several years. This includes our coverage of stem cells, G-protein coupled receptors (GPCRs), and high-content analysis (HCA). As these markets have evolved, we too have evolved our industry coverage to address some of the key bottlenecks/challenges in the drug discovery marketplace as they exist today. This market analysis tutorial focuses upon the market landscape of Toxicity Screening and GPCRs/Kinase Drug Targets in Drug Discovery—specific topics covered are the types of toxicity screening currently performed and associated technologies utilized, market trends in toxicity screening for drug discovery (qualitative and quantitative trends based on end-user market surveys we continually perform), market metrics (size and growth rate), market trends in GPCR and kinase target spaces.
All attendees will receive electronic copies of the various market analyses presented, to complement the presentation and discussion. This is a fast-paced business-focused tutorial, which will include a round-table discussion with your fellow attendees and an un-paralleled networking opportunity with industry participants from around the world working in similar spaces.
This tutorial presents an up-to-date and thorough picture of some key areas impacting drug discovery and is a must-attend for industry professionals looking for the latest market analyses.
Specific Topics Covered in this Tutorial
v Toxicity Screening in Drug Discovery: Segments of the Marketplace and Characteristics
v Technologies and Products for Toxicity Screening
v hERG, LQTS, and Torsades de Pointes
v End-user Market Survey Data: Current Trends and Emerging Themes in Toxicity Screening
v Market Metrics for Toxicity Screening: Size and Growth Rates
v GPCR Market Snapshot: End-user Market Survey Data Provides Current Trends and Emerging Themes
v Kinase Market Snapshot: End-user Market Survey Data Provides Current Trends and Emerging Themes
v Interactive Round-table Discussion and Networking
Who Should Attend
v Scientists in Pharmaceutical and Biotechnology companies
v Business Development, Licensing, and Marketing Executives in Pharmaceutical and Biotechnology companies
v Representatives from Academic Institutions (Licensing and Technology Transfer)
v Established and start-up companies and product/services vendors
v Venture Capital and the investment community
Learning Objectives/Themes
v Overview of the market landscape for toxicity screening in drug discovery
v Market analysis: Qualitative and quantitative
v Emerging business opportunities, and associated challenges
v Review of the various technologies and products in the space
v GPCR and Kinase Drug Target Classes: Market Analysis and End-User Trends
v Interactive round table discussion and networking with attendees from around the world